TME Pharma NV (ALTME) EUR1
€0.0096
(14.46%)
- Add to watchlist
- This stock can be held in a
€0.0096
(14.46%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
€0.0096
(14.46%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Business summary
TME Pharma NV formerly NOXXON Pharma NV is a biotechnology company focusing on developing therapies for the treatment of cancers. The Company specializes in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Its technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. their clinical programs in glioblastoma and pancreatic cancer have delivered results and further development is planned.
Contact details
Important dates
General stock information
- Short code:
- ALTME
- ISIN:
- NL0015000YE1
- Market cap:
- €6.25 million
- Shares in issue:
- 17.28 million
- Sector:
- Biotechnology
- Exchange:
- Euronext Paris
- Country:
- Netherlands
- Currency:
- Euro
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.